Africa Corporate Wellness Market, by End User, 2018-2027
Global Companion Diagnostics market [2016-2027] Americas by Indication
By Indication, the market is segmented into Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Indication_Others (2016-2027)
| Label | Cancer | Neurological Diseases | Infectious Diseases | Cardiovascular Diseases | Indication_Others |
|---|---|---|---|---|---|
| 2016 | 661.25 USD Mn | 137.73 USD Mn | 111.20 USD Mn | 35.42 USD Mn | 81.11 USD Mn |
| 2017 | 709.63 USD Mn | 148.40 USD Mn | 120.53 USD Mn | 38.17 USD Mn | 87.31 USD Mn |
| 2018 | 761.27 USD Mn | 159.84 USD Mn | 130.60 USD Mn | 41.11 USD Mn | 93.94 USD Mn |
| 2019 | 868.03 USD Mn | 182.99 USD Mn | 150.41 USD Mn | 47.06 USD Mn | 107.44 USD Mn |
| 2020 | 524.89 USD Mn | 109.78 USD Mn | 91.14 USD Mn | 27.95 USD Mn | 61.36 USD Mn |
| 2021 | 688.68 USD Mn | 141.09 USD Mn | 119.50 USD Mn | 35.19 USD Mn | 75.82 USD Mn |
| 2022 | 870.94 USD Mn | 174.85 USD Mn | 151.10 USD Mn | 42.73 USD Mn | 90.35 USD Mn |
| 2023 | 1040.93 USD Mn | 204.88 USD Mn | 180.63 USD Mn | 49.06 USD Mn | 101.80 USD Mn |
| 2024 | 1197.05 USD Mn | 231.08 USD Mn | 207.85 USD Mn | 54.21 USD Mn | 110.40 USD Mn |
| 2025 | 1375.45 USD Mn | 260.51 USD Mn | 239.06 USD Mn | 59.88 USD Mn | 119.67 USD Mn |
| 2026 | 1579.14 USD Mn | 293.55 USD Mn | 274.84 USD Mn | 66.11 USD Mn | 129.67 USD Mn |
| 2027 | 1811.49 USD Mn | 330.62 USD Mn | 315.82 USD Mn | 72.95 USD Mn | 140.42 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027] Americas by Indication portion of the Global Companion Diagnostics market [2016 market is on a steady long-term growth path. Segment value stands at roughly USD 2343 Mn in 2026 and is projected to reach USD 2671 Mn by 2027 — a gain of about 14% over the forecast period, translating to a CAGR in the double digits.
- cancer segment accounted for the largest market share in 2019, this market is expected to reach USD 1811. 49 Million in 2027 from USD 868.
- What the regional split looks like (2026): Cancer leads, holding roughly 67% of segment value — the single largest regional share. Neurological Diseases is the second-largest contributor. Infectious Diseases, Indication_Others and Cardiovascular Diseases make up the remainder, in descending order.
- By 2027, Cancer alone is expected to reach USD 1811 Mn, with Neurological Diseases at USD 331 Mn.
Market Dynamics
cancer segment accounted for the largest market share in 2019, this market is expected to reach USD 1811.49 Million in 2027 from USD 868.03 Million in 2019. This market is projected to grow at a CAGR of 19.36% during the forecast period from 2020 - 2027. However, infectious diseases segment is the fastest growing market, which is expected to grow at a CAGR of 19.43% during the forecast period 2020 - 2027.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



